Welcome to Psoriasis Guide
Treating Psoriasis Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
About the National Psoriasis Foundation
from:What is the National Psoriasis Foundation? And what does it do for the people in the USA who suffer from this skin disease known as psoriasis? The National Psoriasis Foundation is actually an organization that helps not only the people of the US, but people from all over the world as well. It is dedicated to find ways to control psoriasis and the different problems it presents. The National Psoriasis Foundation has been around for 35 years, and it has been trying to help improve the lives of people who suffer from different kinds of psoriasis.
The National Psoriasis Foundation is an organization that is funded by the donations of corporations and individuals that are dedicated to help those who need their assistance, like people who are afflicted with psoriatic arthritis or other kinds of psoriasis. Another goal of the National Psoriasis Foundation is to get the information that sufferers of psoriasis need and these include the breakthroughs in treatments, updates on possible cures and other such information that can prove to be very helpful to those who need them.
The National Psoriasis Foundation is also an organization that holds numerous activities for the sufferers of psoriasis to get in touch with the staff and people behind the National Psoriasis Foundation. These activities may include awareness drives, sports activities and other such events that can help foster the spirit of camaraderie and unity among those who know what it is like to have psoriasis, those who care about the people who do have this affliction, and those who want to know more about the illness and what can be done to help sufferers of the disease.
The National Psoriasis Foundation gives out information on almost all the factors that seem to have a bearing on the disease. One of the main causes of concern that the foundation has is the acceptance of the people who suffer the stigma of psoriasis in certain communities. Psoriasis is not a contagious disease, and therefore, people should not fear the individuals who have this disease. With the help of information dissemination, people can easily understand that they have nothing to fear from those who have this rather unsightly and bothersome skin condition.
The information that sufferers and non-sufferers get from the foundation will give you a better understanding of the problem that is psoriasis. You can get information on what current treatments are making great progress in treating the types of psoriasis that are harder to treat, and what other milestones are being reached in the fight against the disease called psoriasis.
Treating Psoriasis Specific links
Treating Psoriasis News
Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical ... - MarketWatch (press release)
Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical ... MarketWatch (press release) In contrast, inhibition of specific TLRs may be useful in treating autoimmune disorders, such as psoriasis and lupus, by blocking the production of multiple pro-inflammatory mediators. Using its chemistry-based approach, Idera is advancing novel drug ... |
Scalp Conditions Handbook: Skincare-News.com Compiles eBook About Treating the ... - Albany Times Union
Scalp Conditions Handbook: Skincare-News.com Compiles eBook About Treating the ... Albany Times Union Get tips on treating and preventing issues like dandruff, scalp acne and psoriasis with this guide from Skincare-News.com. The latest Skincare-News.com eBook Scalp Conditions Handbook is a collection of 12 chapters on various scalp conditions, ... |
Like Curry? New Biological Role Identified for Compound Used in Ancient Medicine - Science Daily (press release)
Like Curry? New Biological Role Identified for Compound Used in Ancient Medicine Science Daily (press release) There has been intense scientific interest in the vitamin D receptor in recent years because of potential therapeutic benefits in treating infection, cancer, psoriasis and other diseases, the researchers noted in their report. |
Idera Pharmaceuticals Announces Presentation of Preclinical Data of IMO-8400 ... - MarketWatch (press release)
Idera Pharmaceuticals Announces Presentation of Preclinical Data of IMO-8400 ... MarketWatch (press release) In contrast, inhibition of specific TLRs may be useful in treating autoimmune disorders, such as psoriasis and lupus, by blocking the production of multiple pro-inflammatory mediators. Using its chemistry-based approach, Idera is advancing novel drug ... |
Idera Pharmaceuticals Reports First Quarter 2012 Financial Results - MarketWatch (press release)
Idera Pharmaceuticals Reports First Quarter 2012 Financial Results MarketWatch (press release) IMO-3100, a dual antagonist of TLR7 and TLR9, is the lead clinical candidate being developed by the Company for the treatment of psoriasis. -- In the second quarter of 2012, the Company initiated a Phase 2 randomized, placebo-controlled clinical trial ... |